Systemic mastocytosis with <i>KIT</i> V560G mutation presenting as recurrent episodes of vascular collapse: response to disodium cromoglycate and disease outcome.

In the 90s, a double-blind, placebo-controlled trial of the efficacy of oral DSCG was conducted in 11 patients with SM; this study showed that DSCG was significantly helpful relative to placebo in alleviating the gastrointestinal manifestations, whereas the benefit for non-gastrointestinal symptoms did not reach statistical significance [ 39 ].

also in 111,027 other papers